ASTRAZENECA PLC - ANNUAL GENERAL MEETING 2016 Results of Annual General Meeting held on 29 April 2016 AstraZeneca PLC announced the results of the voting at its Annual General Meeting today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 1 - 8 were passed as ordinary resolutions and resolutions 9 - 11 were passed as special resolutions. RESOLUTION VOTES FOR % VOTES % VOTES TOTAL VOTES OF AGAINST OF CAST IN VOTES WITHHELD VOTES VOTES TOTAL CAST CAST CAST AS A % OF ISSUED SHARE CAPITAL 1 To receive 924,514,473 99.61 3,665,459 0.39 928,179,932 73.40% 8,998,621 the Company's Accounts and the Reports of the Directors and Auditor for the year ended 31 December 2015 2 To confirm 933,191,043 99.69 2,915,972 0.31 936,107,015 74.03% 1,071,537 dividends 3 To re 929,918,594 99.56 4,151,154 0.44 934,069,748 73.87% 3,108,804 -appoint KPMG LLP, London as Auditor 4 To 934,984,319 99.89 988,556 0.11 935,972,875 74.02% 1,204,865 authorise the Directors to agree the remuneration of the Auditor 5a To re 861,678,834 94.69 48,321,545 5.31 910,000,379 71.96% 27,177,942 -elect Leif Johansson as a Director 5b To re 935,167,473 99.93 697,471 0.07 935,864,944 74.01% 1,342,796 -elect Pascal Soriot as a Director 5c To re 931,875,086 99.58 3,920,615 0.42 935,795,701 74.00% 1,380,982 -elect Marc Dunoyer as a Director 5d To re 935,157,654 99.93 635,873 0.07 935,793,527 74.00% 1,384,110 -elect Cori Bargmann as a Director 5e To re 935,199,102 99.93 622,099 0.07 935,821,201 74.00% 1,356,436 -elect Geneviève Berger as a Director 5f To re 933,026,505 99.70 2,762,355 0.30 935,788,860 74.00% 1,389,088 -elect Bruce Burlington as a Director 5g To re 933,220,149 99.72 2,618,183 0.28 935,838,332 74.01% 1,339,989 -elect Ann Cairns as a Director 5h To re 919,686,570 98.97 9,526,012 1.03 929,212,582 73.48% 7,965,366 -elect Graham Chipchase as a Director 5i To re 933,177,891 99.72 2,593,420 0.28 935,771,311 74.00% 1,406,637 -elect Jean -Philippe Courtois as a Director 5j To re 923,984,532 98.74 11,766,347 1.26 935,750,879 74.00% 1,427,442 -elect Rudy Markham as a Director 5k To re 927,479,182 99.11 8,287,726 0.89 935,766,908 74.00% 1,410,552 -elect Shriti Vadera as a Director 5l To re 870,828,312 95.76 38,511,577 4.24 909,339,889 71.91% 27,837,158 -elect Marcus Wallenberg as a Director 6 To approve 836,396,151 89.61 96,959,428 10.39 933,355,579 73.81% 3,822,290 the Annual Report on Remuneration for the year ended 31 December 2015 7 To 908,106,542 97.83 20,185,176 2.17 928,291,718 73.41% 8,886,009 authorise limited EU political donations 8 To 849,809,843 90.97 84,303,774 9.03 934,113,617 73.87% 3,064,122 authorise the Directors to allot shares 9 To 922,425,478 98.82 11,009,374 1.18 933,434,852 73.82% 3,742,888 authorise the Directors to disapply pre -emption rights 10 To 926,166,577 98.96 9,722,078 1.04 935,888,655 74.01% 1,289,613 authorise the Company to purchase its own shares 11 To reduce 829,946,353 88.85 104,116,202 11.15 934,062,555 73.87% 3,115,081 the notice period for general meetings Issued capital As at 27 April 2016, the number of issued shares of the Company was 1,264,542,488 ordinary shares, which was the total number of shares entitling the holders to attend and vote for or against all the resolutions at the AGM. In accordance with the Company's Articles of Association, on a poll every member present in person or by proxy has one vote for every share held. A C N Kemp Company Secretary 29 April 2016
Result of AGM
| Source: AstraZeneca PLC